Apoptogenic effect of the lipophilic o-naphthoquinone CG 10-248 on rat hepatocytes: Light and electron microscopy studies

Biocell

Volumn 27, Issue 2, 2003, Pages 213-224

  Lopez, Lidia M ^d   Dubin, Marta ^a,c   Carrizo, Patricia H ^a   Burgos, Mario H ^b   De Iraldi, Amanda Pellegrino ^d   Stoppani, Andrés O M ^a  

^a UBA CONICET ^*  (Argentina)

^b Instituto de Histologia y Embriologia   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d NONE

Author keywords

Apoptosis; Blebs; Chromatin alteration; Hepatocytes; Mitochondrial swelling membrane; o naphthoquinones

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 3,4 DIHYDRO 2,2 DIMETHYL 9 CHLORO 2H NAPHTHO[1,2 B]PYRAN 5,6 DIONE; CG 10248; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ULTRASTRUCTURE; CHROMATIN CONDENSATION; ELECTRON MICROSCOPY; LIPOPHILICITY; LIVER CELL; MICROSCOPY; MICROVILLUS; MITOCHONDRIAL MEMBRANE; NONHUMAN; PEROXISOME; RAT; ROUGH ENDOPLASMIC RETICULUM; SMOOTH ENDOPLASMIC RETICULUM;

ANIMALS; APOPTOSIS; CELL SURFACE EXTENSIONS; CELLS, CULTURED; CHROMATIN; DNA FRAGMENTATION; ENDOPLASMIC RETICULUM; HEPATOCYTES; HYDROGEN PEROXIDE; INTRACELLULAR MEMBRANES; MALE; MICROSCOPY, ELECTRON; MICROVILLI; MITOCHONDRIA; NAPHTHOQUINONES; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0042190274     PISSN: 03279545     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Boothman DA, Trask DK, Pardee AB (1989). Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I. Cancer Res 49: 605-612.
2. Chau Y-P, Shiah S-G, Con M-J, Kuo M-L (1998). Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation in human leukemia cells. Free Radical Biol Med 24: 660-670.
3. Chen HW, Chlang T, Wang CY, Lii CK (2000). Inhibition of tert-butyl hydroperoxide-induced cell membrane bleb formation by alphatocopherol and glutathione. Food Chem Toxicol 38: 1089-1096.
4. Degrassi F, De Salvia R, Berghella L (1993). The production of chromosomal alterations by β-lapachone, an activator of topoisomerase I. Mutat Res 288: 263-267.
5. Dolan ME, Frydman B, Thompson CB, Diamond AM, Garbiras BJ, Safa AR, Beck WT, Marton LJ (1998). Effect of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents. Anti-cancer Drugs 9: 437-448.
6. Don M-J, Chang Y-H, Chen K-K, Ho L-K, Chau Y-P (2001). Induction of CDK inhibitors (p21 WAF1 and p27Kip1) and Bak in the β-lapachone induced apoptosis of human prostate cancer cells. Mol Pharmacol 59: 784-794.
7. Dubin M, Stoppani AOM (2000). Muerte celular programada y apoptosis. Medicina 60: 375-386.
8. Dubin M, Carrizo PH, Biscardi AM, Fernandez Villamil SH, Stoppani AOM (1994). Effect of 5-nitroindole on adenylate energy charge, oxidative phosphorylation and lipid peroxidation in rat hepatocytes. Biochem Pharmacol 48: 1483-1492.
9. Dubin M, Fernández Villamil SH, Stoppani AOM (2001). Citotoxicidad de la β-lapcichona, una o-naftoquinona con posibles usos terapéuticos. Medicina-Buenos Aires 61: 343-350.
10. Dubin M, Fernández Villamil SH, De Witte N, Carrizo P, Molina Portela MP, Stoppani AOM (2002). Possible cytotoxic effects of lipophilic o-naphthoquinones in isolated rat hepatocytes. Protective mechanisms. In: Sixth International Symposium on Predictive Oncology and Intervention Strategies, H.E. Nieburgs, Ed. Elsevier Science Inc, p. 179.
11. Fearnhead HO, Dinsdale D, Cohen GM (1995). An interleukin-1β -converting enzyme-like protease is a common mediator of apoptosis in thymocytes. FEBS Lett 375: 283-288.
12. Fernández Villamil SH, Dubin M, Molina Portela MP, Perissinotti L LJ, Brusa MA, Stoppani AOM (1997). Semiquinone production by lipophilic o-naphthoquinones. Redox Report 3: 245-252.
13. Fernández Villamil SH, Podesta D, Molina Portela MP, Stoppani AOM (2001). Characterization of poly(ADP-ribose)polymerase from Crithidia fasciculata: enzyme inhibition by β-lapachone. Mol Biochem Parasitol 115: 249-256.
14. Frydman B, Marton LJ, Sun JS, Neder K, Witiak DT, Liu AA, Wang H-M, Mao Y, Wu H-Y, Sanders MM, Liu LF (1997). Induction of DNA topoisomerase 11-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 57: 620-627.
15. Goijman SG, Stoppani AOM (1985). Effects of β-lapachone, a peroxide-generating quinone, on macromolecule synthesis and degradation in Trypanosoma cruzi. Arch Biochem Biophys 240: 273-280.
16. Hacker G (1999). The morphology of apoptosis. Cell Tissue Res 301: 283-288.
17. Henics T, Wheatley DN (1999). Cytoplasmic vacuolation, adaptation and cell death, a view on new perspectives and features. Bio Cell 91: 485-498.
18. Huang L, Pardee AB (1999). β-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells. Mol Med 5: 711-720.
19. Huot J, Houle F, Rousseau S, Deschesness RG, Shah GM, Landry J (1998). SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 143: 1361-1373.
20. Hyslop PA, Sklar LA (1984). A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of celular activation processes. Arch Biochem Biophys 141: 380-386.
21. Kondo F, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita D (1997). ERM (ezrin/radixin/moesin)-baswd molecular mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol 139: 749-758.
22. Kroemer G (1999). Mitochondrial control of apoptosis: an overview. In: Mitochondria and Cell Death, G.C. Brown, D.G. Nicholls, C.E. Cooper, Eds. Portland Press, pp. 1-15.
23. Li CJ, Wang C, Pardee AB (1995). Induction of apoptosis byfi-lapachone in human prostate cancer cells. Cancer Res 55: 3712-3715.
24. Li Y, Li CJ, Yu D, Pardee AB (2000). Potent induction of apoptosis by β-lapachone in human multiple myeloma cell lines and patient cells. Mol Med 6: 1008-1015.
25. López LM, Pellegrino de Iraldi A, Carrizo PH, Dubin M, Stoppani AOM (2002). Effect of the lipophilic o-naphthoquinone CG 10-248 on rat liver mitochondria structure and function Biocell 26: 237-245.
26. Manna S, Gad YP, Mukhopadhyay A, Aggarwal BB (1999). Suppression of tumor necrosis factor-activated nuclear transcription factorkB, activator protein- 1, c-Jun N-terminal kinase, and apoptosis by β-lapachone. Biochem Pharmacol 57: 763-774.
27. Mirabelli F, Salis A, Marinoni V, Finardi G, Bellomo G, Thör H, Orrenius DS (1988). Menadione-induced blebformation in hepatocytes is associated with the oxidation of thiol groups in actin. Arch Biochem Biophys 264: 261-269.
28. Moldeus P, Högberg J, Orrenius S (1978). Isolation and use of liver cells. Methods Enzymol 52: 60-71.
29. Molina Portela MP, Fernández Villamil SH, Perissinotti LJ, Stoppani AOM (1996). Redox cycling ofo-naphthoquinones in trypanosomatids. Superoxide and hydrogen peroxide production. Biochem Pharmacol 52: 1875-1882.
30. Pardee AB, Li YZ, Li CJ (2002). Cancer therapy with beta-lapachone. Curr Cancer Drug Targets 2: 227-242.
31. Paulino M, Hansz M, Hikichi N, Tabares G, Molina Portela MP, Fernandez Villamil SH, Sreider CM, Stoppani AOM (1994). Propiedades electrónicas y actividad redox de naftoquinonas. An Asoc Quim Argent 82: 371-389.
32. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA (2000a). NAD(P)H: Quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity. J Biol Chem 275: 5416-5424.
33. Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Yang XH, Froelich CJ, Boothman DA (2000b). Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis. Exp Cell Res 255: 144-155.
34. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G, Boothman DA (1995).β-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response. Cancer Res 55: 3706-3711.
35. Planchon SM, Wuerzberger-Davis SM, Pink JJ, Robertson KA, Bornmann WG, Boothman DA (1999). Bcl-2 protects against β-lapachonemediated caspase 3 activation and apoptosis in human myeloid leukemia (HL-60) cells. Oncol Rep 6: 485-492.
36. Schaffner-Sabba K, Schmidt-Ruppin KH, Wehrli W, Schuerch AR, Wasley JWF (1984). β-lapachone: synthesis of derivatives and activities in tumor models. J Med Chem 27: 990-994.
37. Seglen PO (1973). Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp Cell Res 82: 391-398.
38. 2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation dependent pathway. Cancer Res 59: 391-398.
39. Stoppani AOM, Goijman S, Dubin M, Fernández Villamil SH, Molina Portela MP, Biscardi AM, Paulino M (2000). Cytotoxicity of lipophilic o-naphthoquinones: structure-activity relationship. Trends Comp Biochem Physiol 7: 1-16.
40. Thör H, Mirabelli F, Salis A, Cohen GM, Bellomo G, Orrenius S (1988). Alterations in hepatocyte cytoskeleton caused by redox cycling and alkylating quinones. Arch Biochem Biophys 266: 397-407.
41. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB (1997). Bcl-x(L) regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637.
42. Vanni A, Fiore M, De Salvia R, Cundari E, Ricordy R, Ceccarelli R, Degrassi F (1998). DNA damage and cytotoxicity induced by β-lapachone: relation to poly(ADP-ribose)polymerase inhibition. Mutat Res 401: 55-63.
43. Walles S (1992). Mechanism of DNA damage induced in rat hepatocytes by quinones. Cancer Res 63: 47-52.
44. Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG, Bothman DA (1998). Induction of apoptosis in MCF-7: WS8 cancer cells by β-lapachone. Cancer Res 58: 1876-1885.
45. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182: 367-377.
46. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B, Kroemer G (1996). Inhibitors ofpermeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 384: 53-57.